Aprindine
Antiarrhythmic drug
- C01BB04 (WHO)
- {3-[2,3-dihydro-1H-inden-2-yl(phenyl)amino]propyl}diethylamine
- 37640-71-4 Y
- 2218
- DB01429 Y
- 2132 Y
- 5Y48085P9Q
- D02969 Y
- ChEMBL1213033 Y
- DTXSID3022615
- Interactive image
- c1cccc3c1CC(N(c2ccccc2)CCCN(CC)CC)C3
InChI
- InChI=1S/C22H30N2/c1-3-23(4-2)15-10-16-24(21-13-6-5-7-14-21)22-17-19-11-8-9-12-20(19)18-22/h5-9,11-14,22H,3-4,10,15-18H2,1-2H3 Y
- Key:NZLBHDRPUJLHCE-UHFFFAOYSA-N Y
Aprindine is a Class 1b antiarrhythmic agent.[1]
References
- ^ "WHOCC - ATC/DDD Index". WHO Collaborating Centre for Drug Statistics Methodology. Retrieved 2018-03-01.
- v
- t
- e
Antiarrhythmic agents (C01B)
class I (Na+ channel blockers) |
| ||||||
---|---|---|---|---|---|---|---|
class III (Phase 3→, K+ channel blockers) | |||||||
class IV (Phase 4→, Ca2+ channel blockers) |
and antagonists
class II (Phase 4→, β blockers) |
|
---|---|
A1 agonist | |
M2 | |
α receptors |
Na+/ K+-ATPase |
---|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This article about an amine is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e